Series A16 December 2021

Navenio secures £9.5m Series A follow-on funding led by Oxford Science Enterprises

The Oxford Science Enterprises-led round will support US expansion and continued domestic growth in healthcare.

£9.5MSeries A

Navenio provides indoor location technology and task allocation software that streamlines patient care logistics and workforce efficiency in healthcare environments. The Oxford University spinout develops solutions using smartphone sensors to deliver real-time operational insights.

Navenio has secured £9.5m in a Series A follow-on funding round led by Oxford Science Enterprises. The capital will be deployed to support expansion in the US market and foster continued domestic growth. A broad group of existing backers also participated in the round, including QBN Capital, Big Pi Ventures, Future Planet Capital, G.K Goh, Hostplus, Oxford Investment Consultants, IP Group, and the University of Oxford. This follows previous backing, including a $11m investment last year, to further develop the company's indoor location platform and help healthcare providers manage patient flow.

From the founder

"I’m delighted our investors have again demonstrated their belief in the vast potential that Navenio can bring by ensuring ‘right person, right place, right time’. Artificial intelligence is one of many technologies making a real-world impact in the health sector, and this investment enables the company to rapidly spearhead international digital transformation."

Niki Trigoni

Founder and CTO at Navenio

Investor perspective

"We’ve supported Navenio since day one and couldn’t be happier with the progress they have made despite the pandemic. We are proud of the impact this business has made in healthcare and this investment gives the company the firepower to deliver this promise internationally."

Matt Arnold

Principal, Oxford Science Enterprises